Anthony Griffiths

Dr. Anthony Griffiths

National Infectious Diseases Laboratories, Boston University, Boston, United States
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2019 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
GAGaya Amarasinghe
Gaya Amarasinghe
MAMaría Angeles Ayllón
María Angeles Ayllón
YBYiming Bao
Yiming Bao
CBChristopher F Basler
Christopher F Basler
SBSina Bavari
Sina Bavari
Jens H. KuhnJens H. Kuhn
Jens H. Kuhn

2 March 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
TLTammy C. T. Lan
Tammy C. T. Lan
MAMatty F. Allan
Matty F. Allan
LMLauren E. Malsick
Lauren E. Malsick
JWJia Z. Woo
Jia Z. Woo
CZChi Zhu
Chi Zhu
SRSilvia Rouskin
Silvia Rouskin
SARS-CoV-2 is a betacoronavirus with a single-stranded, positive-sense, 30-kilobase RNA genome responsible for the ongoing COVID-19 pandemic. Although population average structure models of the genome were recently reported, there is little experimental data on native structural ensembles, and most structures lack functional characterization. Here we report secondary structure heterogeneity of the entire SARS-CoV-2 genome in two lines of infected cells at single nucleotide resolution. Our results reveal alternative RNA conformations across the genome and at the critical frameshifting stimulation element (FSE) that are drastically different from prevailing population average models. Importantly, we find that this structural ensemble promotes frameshifting rates much higher than the canonical minimal FSE and similar to ribosome profiling studies. Our results highlight the value of studying RNA in its full length and cellular context. The genomic structures detailed here lay groundwork for coronavirus RNA biology and will guide the design of SARS-CoV-2 RNA-based therapeutics.

4 September 2020 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
Jens H. KuhnJens H. Kuhn
Jens H. Kuhn
SAScott Adkins
Scott Adkins
DADaniela Alioto
Daniela Alioto
SASergey Alkhovsky
Sergey Alkhovsky
GAGaya Amarasinghe
Gaya Amarasinghe
XZXueping Zhou
Xueping Zhou

30 December 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NSNadia Storm
Nadia Storm
LMLindsay G. A. McKay
Lindsay G. A. McKay
SDSierra N. Downs
Sierra N. Downs
RJRebecca I. Johnson
Rebecca I. Johnson
DBDagnachew Birru
Dagnachew Birru
AGAnthony Griffiths
Anthony Griffiths
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has devastated global public health systems and economies, with over 52 million people infected, millions of jobs and businesses lost, and more than 1 million deaths recorded to date. Contact with surfaces contaminated with droplets generated by infected persons through exhaling, talking, coughing and sneezing is a major driver of SARS-CoV-2 transmission, with the virus being able to survive on surfaces for extended periods of time. To interrupt these chains of transmission, there is an urgent need for devices that can be deployed to inactivate the virus on both recently and existing contaminated surfaces. Here, we describe the inactivation of SARS-CoV-2 in both wet and dry format using radiation generated by a commercially available Signify ultraviolet (UV)-C light source at 254 nm. We show that for contaminated surfaces, only seconds of exposure is required for complete inactivation, allowing for easy implementation in decontamination workflows.

7 April 2023 in Science
Verified
Journal Article
Open access
ESEllen L. Shrock
Ellen L. Shrock
RTRichard T. Timms
Richard T. Timms
TKTomasz Kula
Tomasz Kula
EMElijah L. Mena
Elijah L. Mena
AWAnthony P. West
Anthony P. West
SEStephen J. Elledge
Stephen J. Elledge
Despite the vast diversity of the antibody repertoire, infected individuals often mount antibody responses to precisely the same epitopes within antigens. The immunological mechanisms underpinning this phenomenon remain unknown. By mapping 376 immunodominant “public epitopes” at high resolution and characterizing several of their cognate antibodies, we concluded that germline-encoded sequences in antibodies drive recurrent recognition. Systematic analysis of antibody-antigen structures uncovered 18 human and 21 partially overlapping mouse germline-encoded amino acid–binding (GRAB) motifs within heavy and light V gene segments that in case studies proved critical for public epitope recognition. GRAB motifs represent a fundamental component of the immune system’s architecture that promotes recognition of pathogens and leads to species-specific public antibody responses that can exert selective pressure on pathogens.

25 August 2023 in Journal of General Virology
Verified
Journal Article
Open access
Jens H. KuhnJens H. Kuhn
Jens H. Kuhn
JAJunya Abe
Junya Abe
SAScott Adkins
Scott Adkins
SASergey Alkhovsky
Sergey Alkhovsky
TATatjana Avsic-Zupanc
Tatjana Avsic-Zupanc
AØArnfinn Lodden Økland
Arnfinn Lodden Økland
In April 2023, following the annual International Committee on Taxonomy of Viruses (ICTV) ratification vote on newly proposed taxa, the phylum Negarnaviricota was amended and emended. The phylum was expanded by one new family, 14 new genera, and 140 new species. Two genera and 538 species were renamed. One species was moved, and four were abolished. This article presents the updated taxonomy of Negarnaviricota as now accepted by the ICTV.